Mithra’s exclusivity on Estetrol applications extended to 2036 in Europe

/in , /by

Thanks to a new patent relating to Estetrol applications, Mithra secures its future results. A similar process is underway for the US market. Liège, Belgique, 30 novembre 2020 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it has been granted a new patent by the European […]

Read more

Estetrol recognized as a “New Active Substance” by the European Medicines Agency (EMA)

/in , /by

This is the first time in more than 80 years that a new estrogen has been introduced in the field of contraception. Liège, Belgium, 25 November 2020 – 7:30 CET – Mithra, a company dedicated to Women’s Health (Euronext Brussels: MITRA), today announces that the European Medicines Agency (EMA) has designated Estetrol monohydrate (E4) as […]

Read more

Creation of a New Share Option Plan in Replacement of the 2018 Share Option Plan

/in , /by

Liege, Belgium, 20 November 2020 – 17:45 CET – Mithra Pharmaceuticals SA (the “Company” or “Mithra”), a company dedicated to Women’s Health (Euronext Brussels: MITRA), today announces that its board of directors has issued, within the framework of the authorized capital, a new share option plan for its personnel, covering 390,717 share options (the “2020 […]

Read more

E4/DRSP, a Novel Combined Oral Contraceptive, submitted to Brazilian regulatory authorities

/in , /by

Liege, Belgium, 17 November 2020 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announced that the regulatory submission for E4/DRSP, a combined oral contraceptive containing estetrol (E4) and drospirenone (DRSP), has been submitted to the National Sanitary Surveillance Agency (ANVISA) by Mithra’s commercial partner, Libbs, the Women’s Health […]

Read more

Mithra Signs License and Supply Agreement for Commercialization of Myring™ in Venezuela

/in , /by

Mithra grants license to Chemical Dampe for commercialization of its vaginal contraceptive ring in Venezuela Strengthening of the commercial presence in Latin and South America Myring™ licenses granted to industry leaders in 36 countries, including the world’s three largest markets Liege, Belgium, 10 November 2020 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated […]

Read more

Mithra Renews its Board of Directors to Support its Operational Ambitions

/in , /by

Liege, Belgium, 3 November 2020, 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, on the initiative of its outgoing Chairman Marc Coucke,  its intention to renew its Board of Directors in accordance with its Strategic Operating Plan.

Read more

Mithra Signs LSA for Commercialization of Estelle® in North Africa

/in , /by

Mithra grants exclusive license to GyneBio Pharma for commercialization of its combined oral contraceptive Estelle® in Algeria, Morocco and Tunisia Deal worth up to EUR 25 million for Mithra over the contract period Agreement follows licensing deals for Estelle® with market leaders in key regions such as U.S., Europe, Australia, South America, ASEAN and Middle […]

Read more

Mithra Announces FDA update

/in , , , /by

Mithra’s US partner Mayne Pharma receives complete response letter from FDA for Myring™ requesting additional data that is not normally requested for generic products Based on the information available to date, Mithra expects to have the necessary data in hand to respond to FDA before year-end No questions or comments have been raised by FDA […]

Read more

Mithra Announces 2020 Half Year Results

/in , /by

Substantial funding transactions of EUR 135 million that should secure Mithra for all future working capital needs, and more so if Estelle® receives marketing authorization Total revenues from licensing milestones for Estelle® of EUR 487 million, with EUR 349 million cash to still be collected (EUR 322 million under IFRS15) with a payment horizon dependent on the […]

Read more

Mithra to Host Webcast for Half Year Financial Results on 24 September 2020

/in , /by

Liege, Belgium, 21 September 2020 – 18:00  CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it will host a live webcast on Thursday, 24 September 2020 at 15:00 CEST/ 09:00 EDT to announce its 2020 Half Year financial and operating results. The live webcast can be accessed on the Mithra website […]

Read more